Research Article
BibTex RIS Cite

Akciğer Tüberkulozu ve AkciğerKanserli Hastalarda Serum MalondialdehidSeviyesi ve Süperoksid Dismutaz Aktivitesi

Year 2004, , 33 - 38, 01.05.2004
https://doi.org/10.1501/Ashd_0000000052

Abstract

Giriş: Artan orandaki epidemiyolojik ve deneysel çalışmalar serbest radikal aktivitesi ile malignensi arasında yakın ilişki olduğunu göstermiştir. Kanser ve tüberkuloz (tb) gibi dejeneratif hastalıklarda serbest radikal
oluşumu ile hücresel savunma mekanizması
arasındaki dengesizlik tariflenmiştir.
Yöntem: Bu çalışmada akciğer kanserli (Ac Ca) ve tb’lu hastaların serumlarında lipid peroksid seviyesi ve antioksidan bir enzim olan süperoksit dismutaz aktivitesi incelenmiştir. Kırkiki hasta ve ondört sağlıklı gönüllü bu çalışmaya dahil edilmiştir. Malondialdehid (MDA) ve superoksid dismutaz (SOD)
aktivitesi serumlarında tespit edildi.
Sonuçlar: Serum MDA seviyeleri tüm
hasta grubunda (Ac Ca ve tb) kontrol grubuna gore daha yüksek bulunmuştur. MDA düzeylerinde grup I ile grup II arasında belirgin fark göstermemektedir (p>0,05). Ac Ca’li hastaların serumlarında incelenen SOD aktivitesi diğer iki gruba göre belirgin olarak düşüktür. Grup I’deki SOD aktivitesi grup II ile karşılaştırıldığında anlamlı azalma tespit edilmiştir (p<0,001). Bu çalışmada, LP seviyesi hem tb’li hem de Ac Ca’li hastalarda yüksek olmasına karşın, SOD aktivitesi Ac Ca’li hastalarda tb’lu hastalara göre belirgin yüksektir

References

  • Halliwell B. Reactive oxygen species in living systems: Source, biochemistry and role in human disease. Am J Med 1991; 91: 14-21.
  • Jung K, Seide 1B, Rudolph B et al. Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells. Free Radical Biol Med 1997; 23: 127-33.
  • Hochstein P, Atallah AS. The nature of oxidants and antioxidant systems in the inhibition of mutation and cancer. Mutat Res 1988; 202: 363-75.
  • Timothy RR, Sharma HM. Free radicals in health and disease. Indian J Clin Pract 1991; 2: 15-25.
  • Cerutti PA. Oxyradicals and cancer. Lancet 1994; 344: 862-3.
  • Menkes MS, Comstock GW, Vuilleumier JP, Helsing KJ, Rider AA, Brookmeyer R. Serum beta- carotene, vitamins A and E, selenium and the risk of lung cancer. N Engl J Med 1986; 315: 1250-4.
  • De Oliveira HG, Rosatto ER, Prolla JC. Pleural fluid adenosine deaminase and lymphocyte proportion: Clinical usefulness in the diagnosis of tuberculosis. Cytopathology 1994; 5: 27-32.
  • Janero DR. Malondialdehyde and thiobarbituric acid reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biol Med 1990; 9: 515-40.
  • Penn ZJ, Steer PJ. Breech presentation. In: James DK, Steer PJ, Weiner CP, Gonik B (eds). High risk Pregnancy. Management options. London: WB Saunders 1996: 173-198.
  • Kwiatkowska G, Piasecka MZ, Piotrowta W and Nowata D. Increased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tb. Resp Med 1999; 93: 272-6.
  • Pryor WA, Godber SS. Noninvasive measures of oxidative stress status in humans. Free Rad Biol Med 1991; 10: 177-184.
  • Yoshika T, Kawada K, Shimada T, Moru M. Lipid peroxidation in maternal and cord blod and protective mechanisms against activated oxygen toxicity in the blood. Am J Obstet Gynecol 1979; 135: 372-6.
  • Yi-Sun, Larry W Oberley and Ying Li. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 3413: 497-500.
  • Durak İ, Canbolat O, Kavutçu M, Öztürk HS; Yurtarslanı Z. Activities of total, cytoplasmic and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J Clin Lab Anal 1996; 10: 17-20.
  • Ward PA, Till GO, Hathermill J, Annesley T.M, Kunbel PG. Systemic complement activation, lung injury and products of lipid peroxidation. J Clin Invest 1985; 76: 517-527.
  • Janoff A. Investigation into the biochemical mechanisms of pulmonary emphysema: effects of cigarette smoke on enzymes and antienzymes in the lung. Respiration 1986; 50 (suppl 1); 13-25.
  • Dormandy TL: Free-Radical oxidation and antioxidants. Lancet 1978; 1: 647-53.
  • Sztrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991; 51: 794-8.
  • Jaruga P, Zastawny TH, Skokowski J, Dizdaroğlu M, Olinsky R. Oxidation DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS letters 1994; 341: 59-64.
  • Demling R, Lalonde C. Relationship between lung injury and lung lipid peroxidation caused by recurrent endotoxemia. Am Rev Respir Dis 1989: 139: 1118-24.
  • Kwee JK, Mitidien E. Alfonso OR: Lowered superoxide dismutase in highly metastatic B 16 melanoma cells. Cancer Lett 1991 57: 199-202.
  • Bhuvarahamarthy V, Balasubramanian N, Govindasamy S. Effect of radiotherapy and chemoradiotherapy on circulating antioxidant system of human uterine cervical carcinoma. Molecular and cellular Biochemistry 1996; 158: 17-23.
  • McCord JM. Fridovich I. Superoxide dismutase. An enzyme function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-55.
  • Zieba M, Suwalski M, Kwiatkowska S et al. Comparison of hydrogen peroxide generation and the content of lipid peroxidation products in lung cancer tissue and pulmonary parenchyma. Respir Med 2000; 94(8): 800-5.
  • Steaper SD, Fabris M, Ferrari V, Carbonare MO, Leon A. Quercatin protects cutaneous tissue- associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radical Biology and Medicine 1997; 222(4): 669-678.
  • Comporti M. Biology of disease: lipid peroxidation and cellular damage in toxic liver injury. Lab Invest 1985; 53: 599-623.
  • Vanisree AJ, Shyamaladevi CS. Status of lipid peroxidation and antioxidant enzymes in malignant (bronchogenic carcinoma) and non-malignant pleura effusions. Indian Journal of cancer 1999; Vol 36: 127-134.

SERUM MALONDIALDEHYDE LEVELS AND SUPEROXIDE DISMUTASE ACTIVITIES IN PULMONARY TUBERCULOSIS AND

Year 2004, , 33 - 38, 01.05.2004
https://doi.org/10.1501/Ashd_0000000052

Abstract

Objectives: An increasing amount of
epidemiological and experimental evidence has
been carried out on the relationship between
free radical activity and malignancy. The
imbalance between free radical production and
cellular defense mechanisms has been
described in cancers and degenerative diseases
like tuberculosis (tb).
Methodology: The present investigation
has been undertaken to study the levels of lipid
peroxide (LP) and antioxidant enzyme
superoxide dismutase (SOD) activities in sera
of lung cancers (Lc) and tb. Forty-two patients
and fourteen healthy cases were enrolled into
the study. Group I had seventeen subjects with
Lc, group II had twenty-five patients with tb
and group III had fourteen healthy cases. The
malondialdehide (MDA) and superoxide
dismutase (SOD) activities in sera were
quantified.
Results: Serum MDA levels in the whole
group of patients (Lc and tb) were much higher
than in healthy controls. The levels of MDA
did not change significantly in the group I vs.
group II (p>0,05). The SOD activity in sera
from patients with Lc was markedly lower than
the other two groups. Activities of SOD in
group I significantly decreased as compared to
the group II (p<0,001). In the present study
although LP levels increased in both tb and Lc
patients, the activities of SOD in Lc cases were
significantly higher than tb patients.

References

  • Halliwell B. Reactive oxygen species in living systems: Source, biochemistry and role in human disease. Am J Med 1991; 91: 14-21.
  • Jung K, Seide 1B, Rudolph B et al. Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells. Free Radical Biol Med 1997; 23: 127-33.
  • Hochstein P, Atallah AS. The nature of oxidants and antioxidant systems in the inhibition of mutation and cancer. Mutat Res 1988; 202: 363-75.
  • Timothy RR, Sharma HM. Free radicals in health and disease. Indian J Clin Pract 1991; 2: 15-25.
  • Cerutti PA. Oxyradicals and cancer. Lancet 1994; 344: 862-3.
  • Menkes MS, Comstock GW, Vuilleumier JP, Helsing KJ, Rider AA, Brookmeyer R. Serum beta- carotene, vitamins A and E, selenium and the risk of lung cancer. N Engl J Med 1986; 315: 1250-4.
  • De Oliveira HG, Rosatto ER, Prolla JC. Pleural fluid adenosine deaminase and lymphocyte proportion: Clinical usefulness in the diagnosis of tuberculosis. Cytopathology 1994; 5: 27-32.
  • Janero DR. Malondialdehyde and thiobarbituric acid reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biol Med 1990; 9: 515-40.
  • Penn ZJ, Steer PJ. Breech presentation. In: James DK, Steer PJ, Weiner CP, Gonik B (eds). High risk Pregnancy. Management options. London: WB Saunders 1996: 173-198.
  • Kwiatkowska G, Piasecka MZ, Piotrowta W and Nowata D. Increased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tb. Resp Med 1999; 93: 272-6.
  • Pryor WA, Godber SS. Noninvasive measures of oxidative stress status in humans. Free Rad Biol Med 1991; 10: 177-184.
  • Yoshika T, Kawada K, Shimada T, Moru M. Lipid peroxidation in maternal and cord blod and protective mechanisms against activated oxygen toxicity in the blood. Am J Obstet Gynecol 1979; 135: 372-6.
  • Yi-Sun, Larry W Oberley and Ying Li. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 3413: 497-500.
  • Durak İ, Canbolat O, Kavutçu M, Öztürk HS; Yurtarslanı Z. Activities of total, cytoplasmic and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J Clin Lab Anal 1996; 10: 17-20.
  • Ward PA, Till GO, Hathermill J, Annesley T.M, Kunbel PG. Systemic complement activation, lung injury and products of lipid peroxidation. J Clin Invest 1985; 76: 517-527.
  • Janoff A. Investigation into the biochemical mechanisms of pulmonary emphysema: effects of cigarette smoke on enzymes and antienzymes in the lung. Respiration 1986; 50 (suppl 1); 13-25.
  • Dormandy TL: Free-Radical oxidation and antioxidants. Lancet 1978; 1: 647-53.
  • Sztrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991; 51: 794-8.
  • Jaruga P, Zastawny TH, Skokowski J, Dizdaroğlu M, Olinsky R. Oxidation DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS letters 1994; 341: 59-64.
  • Demling R, Lalonde C. Relationship between lung injury and lung lipid peroxidation caused by recurrent endotoxemia. Am Rev Respir Dis 1989: 139: 1118-24.
  • Kwee JK, Mitidien E. Alfonso OR: Lowered superoxide dismutase in highly metastatic B 16 melanoma cells. Cancer Lett 1991 57: 199-202.
  • Bhuvarahamarthy V, Balasubramanian N, Govindasamy S. Effect of radiotherapy and chemoradiotherapy on circulating antioxidant system of human uterine cervical carcinoma. Molecular and cellular Biochemistry 1996; 158: 17-23.
  • McCord JM. Fridovich I. Superoxide dismutase. An enzyme function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-55.
  • Zieba M, Suwalski M, Kwiatkowska S et al. Comparison of hydrogen peroxide generation and the content of lipid peroxidation products in lung cancer tissue and pulmonary parenchyma. Respir Med 2000; 94(8): 800-5.
  • Steaper SD, Fabris M, Ferrari V, Carbonare MO, Leon A. Quercatin protects cutaneous tissue- associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radical Biology and Medicine 1997; 222(4): 669-678.
  • Comporti M. Biology of disease: lipid peroxidation and cellular damage in toxic liver injury. Lab Invest 1985; 53: 599-623.
  • Vanisree AJ, Shyamaladevi CS. Status of lipid peroxidation and antioxidant enzymes in malignant (bronchogenic carcinoma) and non-malignant pleura effusions. Indian Journal of cancer 1999; Vol 36: 127-134.
There are 27 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Other ID JA57CB62BF
Journal Section Research Article
Authors

Yıldız Güney This is me

Ayşe Bilgihan This is me

Ulukavak Çiftçi Tansu This is me

Filiz Çimen This is me

Özgür Coşkun This is me

Publication Date May 1, 2004
Submission Date May 1, 2004
Published in Issue Year 2004

Cite

APA Güney, Y., Bilgihan, A., Çiftçi Tansu, U., Çimen, F., et al. (2004). Akciğer Tüberkulozu ve AkciğerKanserli Hastalarda Serum MalondialdehidSeviyesi ve Süperoksid Dismutaz Aktivitesi. Ankara Sağlık Hizmetleri Dergisi, 6(2), 33-38. https://doi.org/10.1501/Ashd_0000000052
AMA Güney Y, Bilgihan A, Çiftçi Tansu U, Çimen F, Coşkun Ö. Akciğer Tüberkulozu ve AkciğerKanserli Hastalarda Serum MalondialdehidSeviyesi ve Süperoksid Dismutaz Aktivitesi. ASHD. May 2004;6(2):33-38. doi:10.1501/Ashd_0000000052
Chicago Güney, Yıldız, Ayşe Bilgihan, Ulukavak Çiftçi Tansu, Filiz Çimen, and Özgür Coşkun. “Akciğer Tüberkulozu Ve AkciğerKanserli Hastalarda Serum MalondialdehidSeviyesi Ve Süperoksid Dismutaz Aktivitesi”. Ankara Sağlık Hizmetleri Dergisi 6, no. 2 (May 2004): 33-38. https://doi.org/10.1501/Ashd_0000000052.
EndNote Güney Y, Bilgihan A, Çiftçi Tansu U, Çimen F, Coşkun Ö (May 1, 2004) Akciğer Tüberkulozu ve AkciğerKanserli Hastalarda Serum MalondialdehidSeviyesi ve Süperoksid Dismutaz Aktivitesi. Ankara Sağlık Hizmetleri Dergisi 6 2 33–38.
IEEE Y. Güney, A. Bilgihan, U. Çiftçi Tansu, F. Çimen, and Ö. Coşkun, “Akciğer Tüberkulozu ve AkciğerKanserli Hastalarda Serum MalondialdehidSeviyesi ve Süperoksid Dismutaz Aktivitesi”, ASHD, vol. 6, no. 2, pp. 33–38, 2004, doi: 10.1501/Ashd_0000000052.
ISNAD Güney, Yıldız et al. “Akciğer Tüberkulozu Ve AkciğerKanserli Hastalarda Serum MalondialdehidSeviyesi Ve Süperoksid Dismutaz Aktivitesi”. Ankara Sağlık Hizmetleri Dergisi 6/2 (May 2004), 33-38. https://doi.org/10.1501/Ashd_0000000052.
JAMA Güney Y, Bilgihan A, Çiftçi Tansu U, Çimen F, Coşkun Ö. Akciğer Tüberkulozu ve AkciğerKanserli Hastalarda Serum MalondialdehidSeviyesi ve Süperoksid Dismutaz Aktivitesi. ASHD. 2004;6:33–38.
MLA Güney, Yıldız et al. “Akciğer Tüberkulozu Ve AkciğerKanserli Hastalarda Serum MalondialdehidSeviyesi Ve Süperoksid Dismutaz Aktivitesi”. Ankara Sağlık Hizmetleri Dergisi, vol. 6, no. 2, 2004, pp. 33-38, doi:10.1501/Ashd_0000000052.
Vancouver Güney Y, Bilgihan A, Çiftçi Tansu U, Çimen F, Coşkun Ö. Akciğer Tüberkulozu ve AkciğerKanserli Hastalarda Serum MalondialdehidSeviyesi ve Süperoksid Dismutaz Aktivitesi. ASHD. 2004;6(2):33-8.